REQUEST A DEMO
Total
USD $0.00
Search more companies

Oncologos del Occidente S.A.S. (Colombia)

Main Activities: Ambulatory Health Care Services
Full name: Oncologos del Occidente S.A.S. Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Oncologos del Occidente S.A.S. is an enterprise in Colombia, with the main office in Armenia. The enterprise currently operates in the Ambulatory Health Care Services sector. It was established on December 30, 1996. 1,128 (2024) employees currently work for Oncologos del Occidente S.A.S.. The company’s latest financial report indicates a net sales revenue increase of 14.37% in 2023. During that time, Oncologos del Occidente S.A.S.’s total assets grew by 14.45%. The net profit margin of Oncologos del Occidente S.A.S. increased by 8.66% in 2023.

Headquarters
Cr. 6 Nro. 2 63 Avenida Centenario
Armenia; Quindio;

Contact Details: Purchase the Oncologos del Occidente S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Oncologos del Occidente S.A.S. report to view the information.
Outstanding Shares:
Purchase the Oncologos del Occidente S.A.S. report to view the information.
Incorporation Date:
December 30, 1996
Key Executives
Purchase this report to view the information.
Legal Representative
Subsidiaries
Coomeva Entidad Promotora de Salud S A en Liquidacion
0.67%
Company Performance
Financial values in the chart are available after Oncologos del Occidente S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
14.37%
Total operating revenue
14.37%
Operating profit (EBIT)
117.64%
EBITDA
16.62%
Net Profit (Loss) for the Period
207.06%
Total assets
14.45%
Total equity
15.1%
Operating Profit Margin (ROS)
6.53%
Net Profit Margin
8.66%
Return on Equity (ROE)
6.35%
Debt to Equity Ratio
1.15%
Quick Ratio
-0.11%
Cash Ratio
-0.16%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?